A particularly noteworthy achievement emerged this quarter: Eli Lilly's tirzepatide franchise overtook Merck's cancer immunotherapy Keytruda to become the world's highest-grossing medication. This ...

Eli Lilly raised its full-year profit and revenue forecast on Thursday as strong appetite for its widely popular weight-loss ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Prime Data Centers, a leading international developer and operator of hyperscale and purpose-built data centers, today announced two additions to its leadership team: Donncha Ó Tuama as Chief Legal ...

Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion  Avidity ...

The cornerstone of this strategic offensive is the drug Tirzepatide, a compound already achieving blockbuster status in other global markets for treating Type 2 diabetes and obesity. Under the brand ...

Cipla, Hindustan Unilever Ltd., Colgate, Laurus Labs, Bharat Forge, and the Auto and Airlines sectors are drawing brokerage commentary today.

Hero MotoCorp Ltd., Vodafone Idea Ltd., Shipping Corporation of India Ltd. and NTPC Green Energy Ltd. are some of the stocks ...

The hidradenitis suppurativa market is poised for strong growth, driven by increasing disease awareness, earlier diagnosis, and expanding treatment access. Advances in biologic and targeted therapies, ...

The pharmaceutical giants behind Wegovy and Mounjaro have recently launched advertisements directing people towards their ...

In Q3, the top 10 TV ad spenders poured a combined $544.8 million into airing their commercials, according to data shared ...